CD19-directed CAR T cells gain traction

Lancet Oncol. 2019 Jan;20(1):2-3. doi: 10.1016/S1470-2045(18)30900-8. Epub 2018 Dec 2.

Author

Stephen J Schuster¹

Affiliation

¹ Lymphoma Program, Abramson Cancer Center of the University of Pennsylvania, Perelman Center for Advanced Medicine, 34th and Civic Center Blvd, Philadelphia, PA 19104, USA. Electronic address: stephen.schuster@uphs.upenn.edu.

PMID: 30518503
DOI: 10.1016/S1470-2045(18)30900-8

No abstract available

Publication types

Comment

MeSH terms

Antigens, CD19 / therapeutic use
Biological Products
Humans
Immunotherapy, Adoptive
Lymphoma, B-Cell*
T-Lymphocytes / immunology
Traction*

Substances

Antigens, CD19
Biological Products
axicabtagene ciloleucel